A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study. (Q52651142)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29549468%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

title

A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29549468%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29549468%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Marcello Moccia

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29549468%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Carla Tortorella

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29549468%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Maria Chiara Buscarinu

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29549468%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Alice Laroni

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29549468%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

7

Viviana Nociti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29549468%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

author name string

Roberta Lanzillo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29549468%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Claudio Gasperini

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29549468%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Roberta Fantozzi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29549468%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Pietro Annovazzi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29549468%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Paola Cavalla

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29549468%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Marta Radaelli

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29549468%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Simona Malucchi

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29549468%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Valentina Torri Clerici

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29549468%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Laura Boffa

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29549468%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Fabio Buttari

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29549468%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Paolo Ragonese

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29549468%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Giorgia Teresa Maniscalco

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29549468%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Massimiliano Di Filippo

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29549468%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Federica Pinardi

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29549468%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Antonio Gallo

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29549468%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Giancarlo Coghe

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29549468%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Ilaria Pesci

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29549468%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Alberto Gajofatto

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29549468%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Massimiliano Calabrese

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29549468%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Eleonora Cocco

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29549468%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Claudio Solaro

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29549468%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

R.I.Re.MS study group

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29549468%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Valentina Tomassini

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29549468%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

publication date

16 March 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29549468%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29549468%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

volume

265

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29549468%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

page(s)

1174-1183

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29549468%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29549468%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00415-018-8831-x

20 March 2020

exact match

0 references

cites work

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group

1 reference

12 December 2020

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

1 reference

12 December 2020

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

12 December 2020

Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group

1 reference

12 December 2020

Interrupted therapy: stopping and switching of the beta-interferons prescribed for MS.

1 reference

12 December 2020

Long-term interferon-beta treatment for multiple sclerosis.

1 reference

12 December 2020

Stopping beta-interferon therapy in multiple sclerosis: an analysis of stopping patterns

1 reference

12 December 2020

1 reference

12 December 2020

Randomized trial of oral teriflunomide for relapsing multiple sclerosis.

1 reference

12 December 2020

Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial.

1 reference

12 December 2020

Pegylated interferon β-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study

1 reference

12 December 2020

Multiple Sclerosis State of the Art (SMART): A Qualitative and Quantitative Analysis of Therapy's Adherence, Hospital Reliability's Perception, and Services Provided Quality

1 reference

12 December 2020

Vitamin K cream reduces reactions at the injection site in patients with relapsing–remitting multiple sclerosis treated with subcutaneous interferon beta – VIKING study

1 reference

12 December 2020

Efficacy of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: integrated analysis of the phase 3 trials

1 reference

12 December 2020

Is it time to target no evident disease activity (NEDA) in multiple sclerosis?

1 reference

12 December 2020

Sustained Effect of Delayed-Release Dimethyl Fumarate in Newly Diagnosed Patients with Relapsing-Remitting Multiple Sclerosis: 6-Year Interim Results From an Extension of the DEFINE and CONFIRM Studies

1 reference

12 December 2020

Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study

1 reference

12 December 2020

Predictors of first-line treatment persistence in a Portuguese cohort of relapsing-remitting multiple sclerosis.

1 reference

12 December 2020

Baseline predictors of persistence to first disease-modifying treatment in multiple sclerosis

1 reference

12 December 2020

Predictors of long-term interferon discontinuation in newly diagnosed relapsing multiple sclerosis

1 reference

12 December 2020

Real-World Adherence and Persistence to Oral Disease-Modifying Therapies in Multiple Sclerosis Patients Over 1 Year

1 reference

12 December 2020

Persistence to oral disease-modifying therapies in multiple sclerosis patients.

1 reference

12 December 2020

Treatment satisfaction with injectable disease-modifying therapies in patients with relapsing-remitting multiple sclerosis (the STICK study).

1 reference

12 December 2020

Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter study.

1 reference

12 December 2020

10.1007/S00415-018-8831-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29549468%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference